Basit öğe kaydını göster

The effect of tocilizumab, anakinra and prednisolone on antibody response to SARS-CoV-2 in patients with COVID-19: A prospective cohort study with multivariate analysis of factors affecting the antibody response

dc.contributor.authorÖzsüt, Halit
dc.contributor.authorEraksoy, Haluk
dc.contributor.authorÖncül, Oral
dc.contributor.authorAğaçfidan, Ali
dc.contributor.authorGül, Ahmet
dc.contributor.authorBaşaran, Seniha
dc.contributor.authorŞimşek-Yavuz, Serap
dc.contributor.authorMeşe, Sevim
dc.contributor.authorÇağatay, Atahan
dc.contributor.authorMedetalibeyoğlu, Alpay
dc.date.accessioned2021-12-10T11:20:22Z
dc.date.available2021-12-10T11:20:22Z
dc.identifier.citationBaşaran S., Şimşek-Yavuz S., Meşe S., Çağatay A., Medetalibeyoğlu A., Öncül O., Özsüt H., Ağaçfidan A., Gül A., Eraksoy H., "The effect of tocilizumab, anakinra and prednisolone on antibody response to SARS-CoV-2 in patients with COVID-19: A prospective cohort study with multivariate analysis of factors affecting the antibody response", INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, cilt.105, ss.756-762, 2021
dc.identifier.issn1201-9712
dc.identifier.othervv_1032021
dc.identifier.otherav_77a63da8-6cf9-4f0f-b6c0-23ed9fc3b8a1
dc.identifier.urihttp://hdl.handle.net/20.500.12627/171698
dc.identifier.urihttps://avesis.istanbul.edu.tr/api/publication/77a63da8-6cf9-4f0f-b6c0-23ed9fc3b8a1/file
dc.identifier.urihttps://doi.org/10.1016/j.ijid.2021.03.031
dc.description.abstractObjectives: Disease severity, previous medications and immunosuppressive agents could affect the antibody response against SARS-CoV-2. This study aimed to analyze variables affecting the humoral response to SARS-CoV-2.
dc.language.isoeng
dc.subjectLife Sciences
dc.subjectHealth Sciences
dc.subjectTemel Bilimler
dc.subjectGeneral Immunology and Microbiology
dc.subjectImmunology
dc.subjectInfectious Diseases
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectİmmünoloji
dc.subjectBULAŞICI HASTALIKLAR
dc.subjectYaşam Bilimleri
dc.titleThe effect of tocilizumab, anakinra and prednisolone on antibody response to SARS-CoV-2 in patients with COVID-19: A prospective cohort study with multivariate analysis of factors affecting the antibody response
dc.typeMakale
dc.relation.journalINTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
dc.contributor.departmentİstanbul Üniversitesi , İstanbul Tıp Fakültesi , Dahili Tıp Bilimleri Bölümü
dc.identifier.volume105
dc.identifier.startpage756
dc.identifier.endpage762
dc.contributor.firstauthorID2737099


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster